Is Alvotech (ALVO) stock Halal?

Alvotech is a biopharmaceutical company that focuses on the development and commercialization of biosimilar medicines. These are biologic medical products highly similar to already approved reference products, offering a cost-effective alternative in the pharmaceutical market. Alvotech specializes in a range of therapeutic areas, including autoimmunity and oncology, aiming to increase patient accessibility to vital biologic treatments. The company leverages advanced biotechnology and manufacturing capabilities to ensure high quality and efficacy of its biosimilars. For Muslim investors, though, the most pressing question is simpler: is Alvotech a Halal investment?

Is Alvotech Shariah compliant?

No. In the October 2026 screening Alvotech (ALVO) does not pass AAOIFI screening: it fails the non-permissible income and interest-bearing debt screens. Medicines and medical devices are permissible, and healthcare companies like Alvotech usually clear the activity screen comfortably. What AAOIFI Shariah Standard No. 21 watches is the financing behind the pipeline: drug development is expensive, and the 30% interest bearing debt cap decides the verdict more often than the science does.

Does Alvotech pass the business activity test?

The activity screen is only part of the picture this month: Alvotech currently fails the non-permissible income and interest-bearing debt screens, so the overall verdict is not compliant regardless of the business itself. Treating illness is permissible work; the scrutiny belongs to the financing behind it.

Is Alvotech's income Halal?

No. Alvotech's income from impermissible sources currently exceeds AAOIFI's 5% revenue ceiling, which makes the stock non-compliant on this screen regardless of the others. The screen is reassessed monthly, so the status can change when new financial statements arrive.

Does Alvotech meet AAOIFI's debt and investment ratio requirements?

Not in full. Interest bearing debt currently exceeds the 30% cap, measured against a market capitalisation of $2.07B (market data as of 1 October 2026), while the other ratio stays within it. One breach is enough to fail the screening; the ratios are reassessed monthly under our Shariah Supervisory Board.

Why do other halal screeners show a different verdict for Alvotech?

Screeners can disagree without either being wrong. AAOIFI Shariah Standard No. 21, which Tabadulat applies, measures interest bearing debt and investments against market capitalisation with a 30% ceiling. MSCI and FTSE measure them against total assets with a 33% ceiling, and S&P and Dow Jones Islamic use a multi year average of market capitalisation. Data dates differ too, because each provider reads filings and prices on its own schedule. The same company can therefore pass one standard and fail another in the same month. Tabadulat publishes one answer, the AAOIFI result as of October 2026, and re-screens it every month.

Tabadulat is an ADGM regulated brokerage whose license covers Shari'a Compliant Regulated Activities, as the FSRA permission names them. New to the terminology? Gharar and Maysir, Sukuk, Zakat and purification are all explained in plain English.

New to the screening method? Read What is Halal Investing? A Guide to Halal Stocks and Islamic Finance